KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹310 Cr | ₹237 Cr | ₹218 Cr | ₹208 Cr | ₹202 Cr |
What is the latest Total Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹310 Cr |
| Mar2024 | ₹237 Cr |
| Mar2023 | ₹218 Cr |
| Mar2022 | ₹208 Cr |
| Mar2021 | ₹202 Cr |
How is Total Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹310 Cr | 30.49 | |
| Mar2024 | ₹237 Cr | 9.17 | |
| Mar2023 | ₹218 Cr | 4.42 | |
| Mar2022 | ₹208 Cr | 3.19 | |
| Mar2021 | ₹202 Cr | - | |
Compare Total Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹549.6 Cr | -6.4% | -10.8% | -1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -6.4% |
-10.8% |
-1.7% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses